New paediatric acute lymphoblastic leukaemia (ALL) treatments have been developed and innovative products are in the pipeline. However, despite many active clinical trials, bridging bench science to clinical development to authorised medicines remains challenging. Research in first-line treatment continues to focus on multidrug chemotherapy with the potential addition of new targeted molecules being studied. Research in second- and third-line treatment represents a shift from cytotoxic intensification to an area of precision medicine through emergent innovative and immuno-oncology products. The collaborative research model in ALL involving different stakeholders should intensify to facilitate bench-to-bedside clinical translation for the benefit of patients.
Micallef, B., Nistico', R., Sarac, S.b., Bjerrum, O.w., Butler, D., Sammut Bartolo, N., et al. (2022). The changing landscape of treatment options in childhood acute lymphoblastic leukaemia. DRUG DISCOVERY TODAY, 27(5), 1483-1494 [10.1016/j.drudis.2022.01.002].
The changing landscape of treatment options in childhood acute lymphoblastic leukaemia
Nistico' R;
2022-05-01
Abstract
New paediatric acute lymphoblastic leukaemia (ALL) treatments have been developed and innovative products are in the pipeline. However, despite many active clinical trials, bridging bench science to clinical development to authorised medicines remains challenging. Research in first-line treatment continues to focus on multidrug chemotherapy with the potential addition of new targeted molecules being studied. Research in second- and third-line treatment represents a shift from cytotoxic intensification to an area of precision medicine through emergent innovative and immuno-oncology products. The collaborative research model in ALL involving different stakeholders should intensify to facilitate bench-to-bedside clinical translation for the benefit of patients.File | Dimensione | Formato | |
---|---|---|---|
The changing landscape of treatment options in childhood acute lymphoblastic leukaemia.pdf
solo utenti autorizzati
Descrizione: The changing landscape of treatment options in childhood acute lymphoblastic leukaemia
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
5.02 MB
Formato
Adobe PDF
|
5.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.